15P - ATM loss in NSCLC increases sensitivity to cisplatin and PARP inhibition
Autor: | Bebb, D.G., Petersen, L.F., Moore, J., Elegbede, A., Lees-Miller, S. |
---|---|
Zdroj: | In Annals of Oncology February 2019 30 Supplement 1:i6-i6 |
Databáze: | ScienceDirect |
Externí odkaz: |